Search earnings tickers

REGN

2024Q1BMO

Regeneron Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-05-02 · Fiscal end 2024-03-31 · Features as of 2024-05-01

← Earnings history

Street

Consensus EPS10.10

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move1.7%

IV front—

P/C full—

P/C front—

Features as of2024-05-01

Run-up

Close—

Ret 5d-0.3%

Ret 10d+0.3%

Ret 20d-5.0%

Ret 30d-6.2%

Print

Actual EPS

9.55Miss

Estimated EPS10.10

Actual revenue

3.1B

Surprise %-5.4%

Beat / missMiss

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction+4.2%

Implied vs actual

Implied 1.7%Actual 0.4%

Gap reaction-0.4%

Day result+3.8%

Next-day upYes

Realized / IV0.23×

Post tape

Post 5d+3.2%

Post 10d+3.2%

Post volume1.1M

Vol ×10d2.27×

Vol ×20d2.25×

Post range5.8%